Wuling Liu
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Retinoids in leukemia and cellular processes 3
- Ubiquitin and proteasome pathways 2
- Bioactive Natural Diterpenoids Research 2
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Babu Gajendran (32 shared papers)Yaacov Ben‐David (30 shared papers)Eldad Zacksenhaus (20 shared papers)Yanmei Li (12 shared papers)Zhenling Zeng (3 shared papers)Jian–Hua Liu (3 shared papers)Dandan He (2 shared papers)Klarke M. Sample (10 shared papers)
In The Last Decade
Wuling Liu
40 papers receiving 394 citations
Peers
Comparison fields: 5 of 85
- Molecular Medicine 119
- Endocrinology 49
- Pollution 43
- Hematology 30
- Toxicology 9
Countries citing papers authored by Wuling Liu
This map shows the geographic impact of Wuling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuling Liu more than expected).
Fields of papers citing papers by Wuling Liu
This network shows the impact of papers produced by Wuling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuling Liu. The network helps show where Wuling Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2019 | 29 | |
| 3 | 2018 | 28 | |
| 4 | 2015 | 25 | |
| 5 | 2017 | 22 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2019 | 18 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Wuling Liu
Wuling Liu is a scholar working on Molecular Biology, Hematology, Immunology, Cancer Research and Genetics, having authored 42 papers that have together received 397 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (3 papers), Antibiotic Resistance in Bacteria (3 papers), Nanoparticles: synthesis and applications (3 papers), Acute Myeloid Leukemia Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Bioactive Natural Diterpenoids Research (2 papers), Cancer Mechanisms and Therapy (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Molecular Medicine (119 citations), Endocrinology (49 citations), Pollution (43 citations), Hematology (30 citations) and Toxicology (9 citations). Wuling Liu has collaborated with scholars based in China, Canada and India. Frequent co-authors include Babu Gajendran, Yaacov Ben‐David, Eldad Zacksenhaus, Yanmei Li, Zhenling Zeng, Jian–Hua Liu, Dandan He, Klarke M. Sample, Luchao Lv and Jing Wang. Their work appears in journals such as BMC Cancer, Frontiers in Microbiology, Journal of Inflammation Research, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.